BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 26848574)

  • 1. Differences in Investigator-Initiated Trials between Japan and Other Countries: Analyses of Clinical Trials Sponsored by Academia and Government in the ClinicalTrials.gov Registry and in the Three Japanese Registries.
    Ito T
    PLoS One; 2016; 11(2):e0148455. PubMed ID: 26848574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT).
    Blümle A; Wollmann K; Bischoff K; Kapp P; Lohner S; Nury E; Nitschke K; Zähringer J; Rücker G; Schumacher M
    BMC Med Res Methodol; 2021 Aug; 21(1):182. PubMed ID: 34465296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of investigator initiated trials and industry sponsored trials on medical practice (IMPACT): rationale and study design.
    Nury E; Bischoff K; Wollmann K; Nitschke K; Lohner S; Schumacher M; Rücker G; Blümle A
    BMC Med Res Methodol; 2020 Oct; 20(1):246. PubMed ID: 33008297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The landscape of investigator-initiated oncology trials conducted in mainland China during the past decade (2010-2019).
    Cao Y; Ye LM; Fan Z; Yang W; Chen LY; Mei Y; He DY; Mo WJ
    Cancer Innov; 2023 Feb; 2(1):79-90. PubMed ID: 38090374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of the registration of clinical trials in UMIN-CTR from 2 June 2005 to 1 June 2010 - focus on Japan domestic, academic clinical trials.
    Tang W; Fukuzawa M; Ishikawa H; Tsutani K; Kiuchi T
    Trials; 2013 Oct; 14():333. PubMed ID: 24124926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010.
    Califf RM; Zarin DA; Kramer JM; Sherman RE; Aberle LH; Tasneem A
    JAMA; 2012 May; 307(17):1838-47. PubMed ID: 22550198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Status and Challenges of Cancer Clinical Trials in Korea.
    Shim BY; Park SH; Lee S; Kim JS; Lee KE; Kang YK; Ahn MJ
    Cancer Res Treat; 2016 Jan; 48(1):20-7. PubMed ID: 25761486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sponsorship and design characteristics of trials registered in ClinicalTrials.gov.
    Roumiantseva D; Carini S; Sim I; Wagner TH
    Contemp Clin Trials; 2013 Mar; 34(2):348-55. PubMed ID: 23380028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigational medicinal products, related costs and hospital pharmacy services for investigator-initiated trials: A mixed-methods study.
    Taji Heravi A; Henn A; Deuster S; McLennan S; Gloy V; Mitter VR; Briel M;
    PLoS One; 2022; 17(3):e0264427. PubMed ID: 35245312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trial registry use in anaesthesiology systematic reviews: A cross-sectional study of systematic reviews published in anaesthesiology journals and the Cochrane Library.
    Umberham BA; Detweiler BN; Sims MT; Vassar M
    Eur J Anaesthesiol; 2017 Dec; 34(12):797-807. PubMed ID: 28731924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Industry-sponsored clinical research outside high-income countries: an empirical analysis of registered clinical trials from 2006 to 2013.
    Murthy S; Mandl KD; Bourgeois FT
    Health Res Policy Syst; 2015 Jun; 13():28. PubMed ID: 26041551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. European survey on national training activities in clinical research.
    Magnin A; Iversen VC; Calvo G; Čečetková B; Dale O; Demlova R; Blasko G; Keane F; Kovacs GL; Levy-Marchal C; Monteiro EC; Palmisano L; Pella D; Portolés Pérez A; Rascol O; Schmid C; Tay F; von der Leyen H; Ohmann C
    Trials; 2019 Oct; 20(1):616. PubMed ID: 31665085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The geographical distribution of leadership in globalized clinical trials.
    Hoekman J; Frenken K; de Zeeuw D; Heerspink HL
    PLoS One; 2012; 7(10):e45984. PubMed ID: 23071532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Trends in the Design, Accrual, and Completion of Trials Registered in ClinicalTrials.gov by Sponsor Type, 2000-2019.
    Gresham G; Meinert JL; Gresham AG; Meinert CL
    JAMA Netw Open; 2020 Aug; 3(8):e2014682. PubMed ID: 32845329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fate of prospective spine studies registered on www.ClinicalTrials.gov.
    Ohnmeiss DD
    Spine J; 2015 Mar; 15(3):487-91. PubMed ID: 25315132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Background, introduction and activity of the Japan Primary Registries Network.
    Shiokawa T
    J Evid Based Med; 2009 Feb; 2(1):41-3. PubMed ID: 21348982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of Asian 4 countries on cancer clinical trials registered in the International Clinical Trials Registry Platform between 2005 and 2018.
    Doi M; Yukawa K; Sato H
    Chin Clin Oncol; 2021 Jun; 10(3):28. PubMed ID: 34182763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consequences of Directive 2001/20/EC for investigator-initiated trials in the paediatric population--a field report.
    Welzing L; Harnischmacher U; Weyersberg A; Roth B
    Eur J Pediatr; 2007 Nov; 166(11):1169-76. PubMed ID: 17333274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Trials in Dentistry: A Cross-sectional Analysis of World Health Organization-International Clinical Trial Registry Platform.
    Sivaramakrishnan G; Sridharan K
    J Evid Based Dent Pract; 2016 Jun; 16(2):90-5. PubMed ID: 27449835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Panoramic quality assessment tool for investigator initiated trials.
    Lv W; Hu T; Jiang J; Qu T; Shen E; Duan J; Miao X; Zhang W; Qian B
    Front Public Health; 2022; 10():988574. PubMed ID: 36176521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.